CLINICAL_TRIALS
trial_result
· 2016-11-08
Clinical Trial Update: Exenatide Once Weekly, Cardiovascular Risk and Type-2 Diabetes [Phase 4]
Summary
A Phase 4 clinical trial evaluating the cardiovascular safety of once-weekly exenatide in adults with type 2 diabetes has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: University of Palermo | Conditions: Type 2 Diabetes Mellitus | Phase 4 | Status: COMPLETED